Corporate Finance in Atlantic Canada

Commentary on corporate finance issues for small- & mid-market private companies in Atlantic Canada

PEI pharma deal

leave a comment »

Los Angeles-based Questcor Pharmacenticals (QCOR on Nasdaq) is acquiring the shares of PEI’s BioVectra for $50 mil in cash (plus up to another $50 mil in earnout consideration).

Questcor is a biopharmaceutical company focused on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders.  BioVectra is a supplier of contract manufacturing services to the pharmaceutical and biotechnology industry.

Written by Dan Jennings

January 4, 2013 at 11:59 am

Posted in Announced Transactions

Tagged with

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: